InspireMD, Inc. (NSPR) CEO Jim Barry on Q2 2018 Results - Earnings Call Transcript
Aug. 7, 2018 | Price: Free! | Source: Seeking Alpha
InspireMD's (NSPR) CEO Jim Barry on Q1 2018 Results - Earnings Call Transcript
May 7, 2018 | Price: Free! | Source: Seeking Alpha
InspireMD's (NSPR) CEO Jim Barry on Q3 2017 Results - Earnings Call Transcript
Nov. 8, 2017 | Price: Free! | Source: Seeking Alpha
InspireMD's (NSPR) CEO Jim Barry on Q1 2017 Results - Earnings Call Transcript
May 12, 2017 | Price: Free! | Source: Seeking Alpha
InspireMD's (NSPR) CEO Alan Milinazzo on Q3 2015 Results - Earnings Call Transcript
Nov. 10, 2015 | Price: Free! | Source: Seeking Alpha
InspireMD's (NSPR) CEO Alan Milinazzo on Q2 2015 Results - Earnings Call Transcript
Aug. 5, 2015 | Price: Free! | Source: Seeking Alpha
InspireMD's (NSPR) CEO Alan Milinazzo on Q1 2015 Results - Earnings Call Transcript
May 11, 2015 | Price: Free! | Source: Seeking Alpha
InspireMD's (NSPR) CEO Alan Milinazzo on Q4 2014 Results - Earnings Call Transcript
March 12, 2015 | Price: Free! | Source: Seeking Alpha
InspireMD's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Nov. 13, 2013 | Price: Free! | Source: Seeking Alpha
Inspiremd Inc - Q3 2013 Earnings Call Transcript
Nov. 11, 2013 | Price: Free! | Source: Earnings Impact
InspireMD Inc - Business Update Transcript
Oct. 30, 2013 | Price: Free! | Source: Earnings Impact
Moez Kassam just provided an update on share ownership of InspireMD - Feb. 14, 2019
Other preliminary proxy statements - Feb. 8, 2019
Inspiremd To Report Fourth Quarter And Fiscal 2018 Financial Results And Provide Business - Feb. 7, 2019
InspireMD director just picked up 130,000 shares - Feb. 6, 2019
InspireMD's CFO AND CAO just picked up 300,000 shares - Feb. 6, 2019
InspireMD director just picked up 195,000 shares - Feb. 6, 2019
InspireMD director just picked up 130,000 shares - Feb. 6, 2019
Departure of Directors or Certain - Feb. 6, 2019
InspireMD's President and CEO just picked up 2,000,000 shares - Feb. 6, 2019
InspireMD director just picked up 130,000 shares - Feb. 6, 2019
InspireMD's CFO AND CAO just picked up 300,000 shares - Feb. 5, 2019
Inspiremd Announces Two Successful Live Clinical Case Transmissions Featuring Cguard - Jan. 24, 2019
Inspiremd’S Cguard™ Embolic Prevention System To Be Prominently Featured In Live Case Transmissions At Linc, 22 - Jan. 22, 2019
Martin D. Hoe just issued a filing suggesting it has sold all of its InspireMD - Jan. 17, 2019
InspireMD: Cguard™ Embolic Prevention System In South Africa - Jan. 14, 2019
Inspiremd Receives Noncompliance Notice From Nyse American - Jan. 11, 2019
Results of Operations and Financial - Jan. 9, 2019
Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of InspireMD - Jan. 3, 2019
Inspiremd Announces Publication Of Meta-Analysis Citing Benefits Of Next Generation Mesh-Covered Carotid Stent Systems - Dec. 18, 2018
InspireMD director just disposed of 65 shares - Dec. 11, 2018
Inspiremd Announces Positive Long-Term Safety And Efficacy Data From Ongoing Cguard™ - Nov. 29, 2018
Inspiremd Announces Regulatory And Reimbursement Approval Of - Nov. 28, 2018
InspireMD director just disposed of 8 shares - Nov. 26, 2018
Inspiremd Announces Upcoming Presentations At The 45Th Annual Symposium On Vascular - Nov. 13, 2018
InspireMD Just Filed Its Quarterly Report: Set forth below is ... - Nov. 6, 2018
Inspiremd Announces Third Quarter 2018 Financial Results And Provides Corporate Update - Nov. 6, 2018
Departure of Directors or Certain - Oct. 26, 2018
Regulation FD - Oct. 10, 2018
Inspiremd Announces Issuance Of Two New U.S. Patents Covering Proprietary Micronet™ - Sept. 17, 2018
InspireMD releases salary data. CEO sees compensation fall -55% - Sept. 11, 2018
Regulation FD - Sept. 6, 2018
Shareholder Director - Aug. 30, 2018
InspireMD: Consolidated Statements Of Operations - Aug. 7, 2018
InspireMD Just Filed Its Quarterly Report: NOTE 10 - SUBSEQUEN... - Aug. 6, 2018
Inspiremd Announces Opening Of First Two Cguard™ Eps Centers Of Excellence - July 24, 2018
Steven Boyd just provided an update on share ownership of InspireMD - July 9, 2018
Regulation FD - July 9, 2018
Patricia Winter just provided an update on share ownership of InspireMD - July 9, 2018
Inspiremd, Inc. Announces Pricing Of $10 Million Underwritten Public Offering - July 5, 2018
Moez Kassam just provided an update on share ownership of InspireMD - July 5, 2018
InspireMD just filed a prospectus, suggesting it plans to soon issue some securities - July 3, 2018
InspireMD Just Received a Notice of Effectiveness - June 29, 2018
Filing under Securities Act Rules 163/433 of free writing prospectuses - June 27, 2018
General form for registration of securities under the Securities Act of 1933 - June 26, 2018
Inspiremd’S Cguard™ Eps Prominently Featured At The 10Th International Congress Of The Polish Society For Vascular Surgery - June 21, 2018
General form for registration of securities under the Securities Act of 1933 - June 15, 2018
InspireMD: Tel Aviv, Israel— June 11, 2018 - - June 12, 2018
InspireMD: From The Paradigm Clinical Study Using Cguard™ Eps - June 1, 2018
InspireMD: In India And Peru - May 7, 2018
InspireMD Just Filed Its Quarterly Report: NOTE 10 – SUBSEQUEN... - May 7, 2018
Inspiremd’S Cguard™ Embolic Prevention System To Be Featured At Icca Stroke 2018 In Warsaw, Poland - April 19, 2018
Statement of acquisition of beneficial ownership by individuals - April 9, 2018
Martin D. Hoe just provided an update on share ownership of InspireMD - April 3, 2018
Entry into a Material Definitive - April 3, 2018
Inspiremd Anticipates Fifth Consecutive Quarter Of Sequential Double Digit Growth; - April 3, 2018
Inspiremd, Inc. Announces Proposed Public Offering Of Common Stock - March 29, 2018
InspireMD just filed a prospectus, suggesting it plans to soon issue some securities - March 29, 2018
InspireMD just filed a prospectus, suggesting it plans to soon issue some securities - March 28, 2018
On March - March 27, 2018
InspireMD Just Received a Notice of Effectiveness - March 14, 2018
Registration statement under Securities Act of 1933 - March 8, 2018
Inspiremd Announces First Patient Treated With Cguard - March 5, 2018
Inspiremd Announces Expansion Of Its Distribution Network - March 1, 2018
InspireMD just filed a prospectus, suggesting it plans to soon issue some securities - Feb. 26, 2018
Inspiremd, Inc. Announces Proposed Public Offering Of Common Stock - Feb. 26, 2018
InspireMD Just Received a Notice of Effectiveness - Feb. 23, 2018
InspireMD: Nspiremd Announces Exclusive Distribution, Sales And Marketing Agreement For Cguard™ Eps In South Korea - Feb. 22, 2018
Entry into a Material Definitive - Feb. 21, 2018
Registration statement under Securities Act of 1933 - Feb. 21, 2018
Inspiremd Announces Commercial Launch - Feb. 20, 2018
Renaissance Technologies LLC just provided an update on share ownership of InspireMD - Feb. 14, 2018
Inspiremd Announces Fourth Quarter And Year-End 2017 Results; - Feb. 14, 2018
Inspiremd Announces 1-For-35 Reverse Stock Split - Feb. 7, 2018
Inspiremd’S Cguard™ Embolic Prevention System - Feb. 1, 2018
InspireMD's President and CEO just disposed of 11 shares - Jan. 29, 2018
Inspiremd’S Cguard™ Embolic Prevention System - Jan. 26, 2018
Inspiremd Announces Publication Of An Independent Imaging Study - Jan. 19, 2018
InspireMD: Jim Barry, Craig Shore From: David Waldman, Natalya Rudman Business Update Call - Jan. 10, 2018
Results of Operations and Financial - Jan. 10, 2018
InspireMD: Financial Statements And Exhibits - Jan. 10, 2018
Inspiremd Announces Regulatory Approval Of Cguard™ Eps In India; - Jan. 8, 2018
InspireMD: Item 8.01 Other Events - Jan. 8, 2018
Other definitive proxy statements - Dec. 26, 2017
Material Modification to Rights of Security - Dec. 22, 2017
Inspiremd’S Cguard™ Embolic Prevention System Once Again Featured In A - Dec. 18, 2017
Preliminary Proxy Soliciting materials - Dec. 15, 2017
Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of InspireMD - Dec. 14, 2017
Material Modification to Rights of Security - Dec. 12, 2017
Notice of Exempt Offering of Securities, item 06b - Dec. 12, 2017
Entry into a Material Definitive - Dec. 8, 2017
Other preliminary proxy statements - Dec. 5, 2017
InspireMD: Paradigm Clinical Study Using Cguard™ Eps - Dec. 5, 2017
Inspiremd Announces Expansion Of Its Distribution Network - Dec. 4, 2017
Material Modification to Rights of Security - Dec. 4, 2017
Inspiremd Announces Planned Recapitalization - Nov. 29, 2017
InspireMD Just Filed Its Quarterly Report: NOTE 6- NET LOSS PE... - Nov. 7, 2017
Inspiremd Announces Third Quarter 2017 Results; - Nov. 7, 2017
Submission of Matters to a Vote of Security - Oct. 31, 2017
New York Stock Exchange Accepts Inspiremd’S Plan To Regain Compliance - Oct. 25, 2017